Skip to main content

Advertisement

Log in

Comparative profiling of metabolism-related gene expression in pre-eclamptic and normal pregnancies

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract.

Extensive endothelial dysfunction has been regarded as the central hallmark in the pathogenesis of pre-eclampsia, but the mechanisms leading to this dysfunction remain unclear. The levels of many metabolism substances, such as lipid peroxides, are changed in plasma of patients with pre-eclampsia. Some of those might be associated with the occurrence of pre-eclampsia. Our research was trying to reveal the source of metabolism substances which were elevated in plasma of preeclamptic patients. The expression of many metabolism-associated genes in 3 preeclamptic and strictly matched 3 normal placentas were compared by employing DNA chip representing 243 human hormone-associated genes. The results showed that, many redox metabolism-related genes (GenBank: U78168, X16699, D32143, AL035079, AF069668, X53463, J03746, X02317, X91247, etc) were found more highly expressed in preeclamptic placenta than that in normal placenta. Additionally, the mRNA levels of some genes which were related to other metabolism such as hormone (GenBank: NM_001718, Z22535, M38180, M76665, X75252, J03258, U56725), were also higher in placenta of patients with pre-eclampsia. Furthermore, many transcription factor genes were also up-regulated in pre-eclampsia. It suggested that, the change of genes expression in placenta was associated with the change of metabolism in patients with pre-eclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baelde HJ, Cleton-Jansen AM, van Beerendonk H, Namba M, Bovee JV, Hogendoorn PC (2001) High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol 54:778–782

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Barros JS, Baptista MG, Bairos VA (2002) Human chorionic gonadotropin in human placentas from normal and preeclamptic pregnancies. Arch Gynecol Obstet 266:67–71

    Article  CAS  PubMed  Google Scholar 

  3. Dekker GA, Sibai BM (1998) Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obstet Gynecol 179:1359–1375

    Article  CAS  PubMed  Google Scholar 

  4. Dietl J (2000) The pathogenesis of pre-eclampsia: new aspects. J Perinat Med 28:464–471

    Article  CAS  PubMed  Google Scholar 

  5. Elsheikh A, Creatsas G, Mastorakos G, Milingos S, Loutradis D, Michalas S (2001) The reninaldosterone system during normal and hypertensive pregnancy. Arch Gynecol Obstet 264:182–185

    Article  CAS  PubMed  Google Scholar 

  6. Faxen M, Nisell H, Kublickiene KR (2000) Altered gene expression of endothelin-A and endothelin-B receptors, but not endothelin-1, in myometrium and placenta from pregnancies complicated by pre-eclampsia. Arch Gynecol Obstet 264:143–149

    Article  CAS  PubMed  Google Scholar 

  7. Faxen M, Nisell H, Kublickiene KR (2001) Altered mRNA expression of ecNOS and iNOS in myometrium and placenta from women with pre-eclampsia. Arch Gynecol Obstet 265:45–50

    Article  CAS  PubMed  Google Scholar 

  8. Goldstein DP, Berkowitz RS (1994) Current management of complete and partial molar pregnancy. J Reprod Med 39:139–146

    CAS  PubMed  Google Scholar 

  9. Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M, Larrea F (2000) Pre-eclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 85:1828–1833

    CAS  PubMed  Google Scholar 

  10. Hamer I, Wattiaux R, Wattiaux-De Coninck S (1995) Deleterious effects of xanthine oxidase on rat liver endothelial cells after ischemia/reperfusion. Biochim Biophys Acta 1269:145–152

    Article  PubMed  Google Scholar 

  11. Hefler LA, Tempfer CB, Bancher-Todesca D, Schatten C, Husslein P, Heinze G (2001) Placental expression and serum levels of cytokeratin-18 are increased in women with pre-eclampsia. J Soc Gynecol Investig 8:169–173

    Article  CAS  PubMed  Google Scholar 

  12. Hubel CA (1998) Dyslipidemia, iron, and oxidative stress in pre-eclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 16:75–92

    Article  CAS  PubMed  Google Scholar 

  13. Hubel CA, Roberts JM (1999) Lipid metabolism and oxidative stress. In: Linhheimer MD, Roberts JM, Cunningham FG (ed) Chesley's hypertensive disorders in pregnancy, 2nd edn. Appleton and Large, Stanford, pp 453–475

  14. Katusic ZS, Vanhoutte PM (1991) Superoxide anion and endothelial regulation of arterial tone. Semin Perinatol 15:30–33

    CAS  PubMed  Google Scholar 

  15. Loverro G, Pansini V, Greco P, Vimercati A, Parisi AM, Selvaggi L (2001) Indications and outcome for intensive care unit admission during prerperium. Arch Gynecol Obstet 265:195–198

    Article  CAS  PubMed  Google Scholar 

  16. Norwitz ER, Repke JT (2000) Pre-eclampsia: prevention and management. J Soc Gynecol Investig 7:21–36

    Article  CAS  PubMed  Google Scholar 

  17. Ozkan SO, Korbeyli B, Bese T, Erel CT (2001) Acute cortical blindness complicating pre-eclampsia. Arch Gynecol Obstet 265:231–232

    Article  CAS  PubMed  Google Scholar 

  18. Pang ZJ, Zhou M, Chen Y, Wan J (1998) A protein-bound polysaccharide synergistically with lipopolysaccharide induces the nitric oxide release and antioxidant enzymes activities in mouse peritoneal macrophages. Am J Chin Med 26:133–141

    Article  CAS  PubMed  Google Scholar 

  19. Pang ZJ, Chen Y, Zhou M (2000) L929 cell conditioned medium protects RAW264.7 cell from oxidative injury through inducing antioxidant enzymes. Cytokine 12:944–950

    Article  CAS  PubMed  Google Scholar 

  20. Rdeman CW, Sacks GP, Sargent IL (1999) Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180:499–506

    Article  Google Scholar 

  21. Roberts JM (2000) Pre-eclampsia: what we know and what we do not know. Semin Perinatol 24:24–28

    Article  CAS  PubMed  Google Scholar 

  22. Sacks G, Sargent I, Redman C (1999) An innate view of human pregnancy. Immunol Today 20:114–118

    Article  CAS  PubMed  Google Scholar 

  23. Taylor RN, Roberts JM (1999) Endothelial cell dysfunction. In: Linhheimer MD, Roberts JM, Cunningham FG (ed) Chesley's hypertensive disorders in pregnancy, 2nd edn. Appleton and Large, Stanford, pp 395–429

  24. Wacker J, Fruhauf J, Schulz M, Chiwora FM, Volz J, Becker K (2000) Riboflavin deficiency and pre-eclampsia. Obstet Gynecol 96:38–44

    CAS  PubMed  Google Scholar 

  25. Walsh SW (1985) Pre-eclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 152:335–340

    Article  CAS  PubMed  Google Scholar 

  26. Zeeman GG, Dekker GA (1992) Pathogenesis of pre-eclampsia: a hypothesis. Clin Obstet Gynecol 35:317–337

    Article  CAS  PubMed  Google Scholar 

  27. Ziadeh S, Yahaya A (2001) Pregnancy outcome at age 40 and older. Arch Gynecol Obstet 265:30–33

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement.

This work was supported by the Special Funds for Major State Basic Research Project (Grant No. G1999055903).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhan-Jun Pang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pang, ZJ., Xing, FQ. Comparative profiling of metabolism-related gene expression in pre-eclamptic and normal pregnancies. Arch Gynecol Obstet 269, 91–95 (2004). https://doi.org/10.1007/s00404-002-0413-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-002-0413-5

Keywords.

Navigation